AAA Statement

Advanced Accelerator Applications, a Novartis company, is an innovative medicines company focused on the development of products for targeted radioligand therapy and precision radioligand imaging. We are committed to transforming patients’ lives by leading innovation in nuclear medicine.
AAA offers professionals the opportunity to face new challenges and pursue a career in a fast growing, technology driven healthcare company. We are passionate about improving patient health by leading innovation in nuclear medicine. We are looking for people who share our commitment to help us achieve this goal. Advanced Accelerator Applications is an Equal Opportunity Employer (EOE).

Quality Control Technician - AAA
Advanced Accelerator Applications, a Novartis company, is an innovative medicines company focused on the development of products for targeted radioligand therapy and precision radioligand imaging. We are committed to transforming patients’ lives by leading innovation in nuclear medicine.




AAA offers professionals the opportunity to face new challenges and pursue a career in a fast growing, technology driven healthcare company. We are passionate about improving patient health by leading innovation in nuclear medicine. We are looking for people who share our commitment to help us achieve this goal. Advanced Accelerator Applications is an Equal Opportunity Employer (EOE).
Over 1000 associates at 31 sites in 12 countries currently make up Advanced Accelerator Applications. AAA is also an expanding business where we have the unique advantage to leverage the size and scale of Novartis, while working in a culture that is unbossed, curious and inspired - all to create impact for patients.
The Quality Control Technician will be responsible to perform the analysis on batches and incoming materials according to cGMP rules and SOPs.
Your key responsibilities:Your responsibilities include, but are not limited to:
- Perform the Quality Control analysis on the final pro

📌 Qc Technician Pozzilli
🏢 Novartis
📍 Pozzilli